Share on StockTwits

Research analysts at Leerink Swann initiated coverage on shares of Auris Medical Holding AG (NASDAQ:EARS) in a report released on Tuesday. The firm set an “outperform” rating on the stock.

A number of other analysts have also recently weighed in on EARS. Analysts at JMP Securities initiated coverage on shares of Auris Medical Holding AG in a research note on Tuesday. They set an “outperform” rating on the stock. Analysts at Jefferies Group initiated coverage on shares of Auris Medical Holding AG in a research note on Tuesday. They set a “buy” rating on the stock.

Auris Medical Holding AG (NASDAQ:EARS) opened at 6.15 on Tuesday. Auris Medical Holding AG has a 52 week low of $6.00 and a 52 week high of $6.80. The stock’s 50-day moving average is $6.28 and its 200-day moving average is $6.28. The company’s market cap is $173.7 million.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.